Parallax Volatility Advisers, L.P. Omeros Corp Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$12.21 - $16.99 $169,633 - $236,042	-13,893 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.03 - $19.72 $125,453 - $273,969	13,893 New	13,893 $186,000
Q1 2019 May 15, 2019	SELL	$11.65 - $17.72 $127,264 - $193,573	-10,924 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$10.72 - $16.73 $116,483 - $181,788	10,866 Added 18734.48%	10,924 $122,000
Q3 2018 Nov 14, 2018	SELL	$17.73 - $26.69 $299,105 - $450,260	-16,870 Reduced 99.66%	58 $1,000
Q2 2018 Aug 14, 2018	BUY	$10.79 - $24.44 $182,653 - $413,720	16,928 New	16,928 $307,000
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $62,370 - $139,708	-6,930 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.26 - $22.86 $91,891 - $158,419	6,930	6,930 $135,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $647M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.